NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

A preliminary study set to be presented at the American Heart Association’s Scientific Sessions 2025 says that the long-term ...

A study presented at the American Heart Association's scientific meetings has raised concerns about melatonin, one of Britain ...

Preclinical data with a gene therapy has shown potential to restore cardiac function in a rat model of for heart failure.

New research linked long-term melatonin use with heart failure risk. However, more research is needed to validate the findings.

In patients with preserved heart function after a heart attack, beta-blockers did not improve outcomes, according to a ...

Don't lose sleep over headlines linking melatonin to heart failure. That's the message after some scary-sounding reports ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...

Panelists discuss how payers typically require step therapy with SGLT2 inhibitors before approving nonsteroidal MRAs due to ...

When retired Marine Corps officer Steve Snowden faced the biggest battle of his life—heart failure at age 81—he turned to the ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...